PURA – Puration Reports $1.2 Million In Revenue With $500,000 Net Profit In 2018 Year-End Financial Report

Puration, Inc.

DALLAS, April 16, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Puration, Inc. (USOTC: PURA) (“PURA”) today announced filing the company’s annual financial statement reporting over $1.2 million in revenue for year-end December 31, 2018 with over $500,000 in net profit. Management attributes the more than 350% revenue growth in 2018 from the less than $300,000 in revenue reported in 2017 to the success of the company’s EVERx CBD Sports Beverage. With the company’s recently reported enhanced partnership with Kali-Extracts, (USOTC: KALY) (“KALY”), management expects cannabis beverage diversification and continued rapid growth in 2019. PURA is working closely with the company’s co-packer/partner Alkame Holdings, (USOTC: ALKM) to expand production capacity and keep up with PURA’s growing sales. PURA is also working with North American Cannabis Holdings, (aka USMJ) (USOTC: USMJ) to update PURA’s distribution channels to keep up with USMJ’s online retail sales at USMJ.com and simultaneously meet wholesale demand. On Friday, this week, April 19th, 2019, PURA management will publish an online shareholder report with more details and insight on the company’s 2018 growth and ongoing anticipated growth in 2019. The online report is expected to include updates on PURA’s work with KALY to produce new beverages and work with ALKM to increase production capacity and produce new beverages.
For more information on Puration, visit http://www.purationinc.com

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Puration, Inc.
Brian Shibley,
(800) 861-1350

The Motley Fool
Contributor at mjcanada.ca
The Motley Fool is dedicated to helping the world invest — better. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, mutual funds, and premium investing services.

In all we do, we take a different approach.

We believe – and have proven over decades – that the individual investor can beat the market.

We believe that anyone can do it, even if they don’t have a lot of time or money to devote to investing.

We believe in a long-term outlook, helping people build wealth over time.

We believe that the person best positioned to take care of your financial future is you.

And we work tirelessly on behalf of our hundreds of thousands of members who are enjoying the opportunities that come with having enough money to do the things that matter to them.

While we are headquartered in Alexandria, Va., The Motley Fool advocates for the individual investor around the globe with offices in the UK, Australia, Canada, Singapore, and Germany.

Related News